Related Topics News -

     
 Title only   |   Print    Next page > 
     
《業績》綠葉製藥中期純利3.9億人民幣 增長24.8%

2026-08-31T  
綠葉製藥mRNA疫苗LY01620即將開展II期臨床試驗

2026-08-21T  
綠葉製藥創新藥LY03015在美完成橋接臨床試驗

2026-08-05T  
內地新一批國家藥品集採納入65個品種

2026-08-03T  
特朗普:2028年8月起對進口仿製藥徵收100%關稅

2026-07-22T  
中國上半年創新藥對外授權交易額逾1,000億美元 再創新高

2026-07-20T  
中國上半年創新藥對外授權交易總額增至1,100億美元 再創新高

2026-07-13T  
綠葉製藥完成提前贖回1.8億美元到期可轉換債券

2026-07-07T  
綠葉製藥創新藥LY03015治療遲發性運動障礙臨床研究取得積極結果

2026-06-17T  
綠葉製藥完成發行1.8億美元可轉換債券

2026-06-11T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.